Literature DB >> 1517476

Elevated levels of the IgG2 subclass in serum from patients with a history of destructive periodontal disease. A case-control study.

J M Wilton1, T J Hurst, J A Sterne, J Caves, C Tilley, J R Powell.   

Abstract

The levels of the 4 subclasses of IgG were estimated in the serum from 35 patients with a history of chronic periodontitis and 35 matched controls. The levels of IgG2 were significantly (P less than 0.019) elevated in the patients (3.756 g l-1) compared to the controls (2.882 g l-1). The data suggest that the predominant antibody response to periodontal pathogens in periodontitis may be directed against carbohydrate or glycolipid antigens.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1517476     DOI: 10.1111/j.1600-051x.1992.tb00652.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  4 in total

1.  Relevance of immunoglobulin G Fc receptor polymorphism to recurrence of adult periodontitis in Japanese patients.

Authors:  T Kobayashi; N A Westerdaal; A Miyazaki; W L van der Pol; T Suzuki; H Yoshie; J G van de Winkel; K Hara
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

2.  Serum immunoglobulin G subclass concentrations in periodontally healthy and diseased individuals.

Authors:  H Lu; M Wang; J C Gunsolley; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

3.  Neutrophils in chronic and aggressive periodontitis in interaction with Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans.

Authors:  A Guentsch; M Puklo; P M Preshaw; E Glockmann; W Pfister; J Potempa; S Eick
Journal:  J Periodontal Res       Date:  2009-02-06       Impact factor: 4.419

4.  Cleavage of IgG1 in gingival crevicular fluid is associated with the presence of Porphyromonas gingivalis.

Authors:  A Guentsch; C Hirsch; W Pfister; B Vincents; M Abrahamson; A Sroka; J Potempa; S Eick
Journal:  J Periodontal Res       Date:  2012-11-01       Impact factor: 4.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.